Live Breaking News & Updates on Jessica Cotrone

Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer
Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer
CAMBRIDGE, Mass., Dec. 21, 2020 Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered product candidates which act in the small intestine to drive systemic effects, today announced the appointment of Jonathan Zung, Ph.D., as Chief Development Officer and a member of the Evelo Executive Team. Dr. Zung is an established industry veteran, who brings more than 25 years of global pharmaceutical development and commercialization experience to Evelo. ....

United Kingdom , Jessica Cotrone , Jonathan Zung , Evelo Biosciences , Evelo Biosciences Inc , Evelo Executive Team , Commercialization Services At Covance Drug Development , Bristol Myers Squibb , Clinical Development , Chief Development Officer , Evelo Executive , Simba Gill , Chief Executive Officer , Group President , Commercialization Services , Covance Drug Development , Private Securities Litigation Reform Act , Quarterly Report , ஒன்றுபட்டது கிஂக்டம் , ஏவேலோ உயிர் அறிவியல் , ஏவேலோ உயிர் அறிவியல் இன்க் , ஏவேலோ நிர்வாகி அணி , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , மருத்துவ வளர்ச்சி , தலைமை வளர்ச்சி அதிகாரி , ஏவேலோ நிர்வாகி ,